BioCentury | May 17, 2018
Finance

Europe’s piece of the pie

...and tau, two preclinical European companies are pursuing different targets. Irish blood-brain barrier delivery startup Junction Therapeutics Ltd....
...IMI), Brussels, Belgium Iterum Therapeutics Ltd., Dublin, Ireland Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Junction Therapeutics Ltd....
BioCentury | Aug 17, 2017
Targets & Mechanisms

GRP-THINK AT THE BBB

...the therapy to enter the brain by diffusing through the spaces between endothelial cells. (3) Junction Therapeutics Ltd....
...κ light polypeptide gene enhancer in B cells 1; TFRC (TFR; CD71) - Transferrin receptor Junction Therapeutics Ltd....
...Companies and Institutions Mentioned Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. Genentech Inc., South San Francisco, Calif. Junction Therapeutics Ltd....
BioCentury | Jul 26, 2017
Emerging Company Profile

Breaching the gates

...studies of the siRNAs in lysosomal storage diseases and chronic traumatic encephalopathy (CTE). COMPANY PROFILE Junction Therapeutics Ltd....
...TSX-V:BTI; OTCQB:BIOAF), Vancouver, B.C. CarThera S.A.S., Paris, France Denali Therapeutics Inc., South San Francisco, Calif. Junction Therapeutics Ltd....
...al. “Autoregulated paracellular clearance of amyloid-β across the blood-brain barrier.” Science Advances (2015) Stephen Hansen, Associate Editor Junction Therapeutics Ltd. Claudin...
Items per page:
1 - 3 of 3
BioCentury | May 17, 2018
Finance

Europe’s piece of the pie

...and tau, two preclinical European companies are pursuing different targets. Irish blood-brain barrier delivery startup Junction Therapeutics Ltd....
...IMI), Brussels, Belgium Iterum Therapeutics Ltd., Dublin, Ireland Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Junction Therapeutics Ltd....
BioCentury | Aug 17, 2017
Targets & Mechanisms

GRP-THINK AT THE BBB

...the therapy to enter the brain by diffusing through the spaces between endothelial cells. (3) Junction Therapeutics Ltd....
...κ light polypeptide gene enhancer in B cells 1; TFRC (TFR; CD71) - Transferrin receptor Junction Therapeutics Ltd....
...Companies and Institutions Mentioned Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. Genentech Inc., South San Francisco, Calif. Junction Therapeutics Ltd....
BioCentury | Jul 26, 2017
Emerging Company Profile

Breaching the gates

...studies of the siRNAs in lysosomal storage diseases and chronic traumatic encephalopathy (CTE). COMPANY PROFILE Junction Therapeutics Ltd....
...TSX-V:BTI; OTCQB:BIOAF), Vancouver, B.C. CarThera S.A.S., Paris, France Denali Therapeutics Inc., South San Francisco, Calif. Junction Therapeutics Ltd....
...al. “Autoregulated paracellular clearance of amyloid-β across the blood-brain barrier.” Science Advances (2015) Stephen Hansen, Associate Editor Junction Therapeutics Ltd. Claudin...
Items per page:
1 - 3 of 3